Alto Neuroscience Inc. (ANRO) is a publicly traded Healthcare sector company. As of May 21, 2026, ANRO trades at $20.77 with a market cap of $765.05M and a P/E ratio of -8.22. ANRO moved +1.71% today. Year to date, ANRO is +25.71%; over the trailing twelve months it is +614.09%. Its 52-week range spans $1.60 to $28.44. Analyst consensus is strong buy with an average price target of $35.22. Rallies surfaces ANRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alto Neuroscience Inc. (ANRO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ANRO moved +1.71% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $20.77 |
| Market Cap | $765.05M |
| P/E Ratio | -8.22 |
| EPS | $-2.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.44 |
| 52-Week Low | $1.60 |
| Volume | 187.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-61.43M |
| Gross Margin | 0.00% |
11 analysts cover ANRO: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $35.22.